Last reviewed · How we verify
D5NS
At a glance
| Generic name | D5NS |
|---|---|
| Sponsor | MemorialCare |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic? (NA)
- IV Glucose for Dehydration Treatment (PHASE2)
- Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas (PHASE2)
- S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia (PHASE2)
- Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas (NA)
- A Study on the Effects of Dextrose Solutions on the Course of Labor (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- D5NS CI brief — competitive landscape report
- D5NS updates RSS · CI watch RSS
- MemorialCare portfolio CI